Neural Stem Cell Transplant May Improve Survival, Function in ALS Patients, Trial Results Show – ALS News Today
ALS News Today |
Neural Stem Cell Transplant May Improve Survival, Function in ALS Patients, Trial Results Show
ALS News Today The biopharma company Neuralstem recently announced the long-term follow-up results of the Phase 1 and Phase 2 trials of spinal neural stem cell transplants in ALS patients. The Phase 1 trial (NCT01348451) evaluated the safety and feasibility of … |
